Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Romania’s Largest Media Content Creator Selects Verimatrix Streamkeeper: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Romania’s Largest Media Content Creator Selects Verimatrix Streamkeeper


Regulatory News:



Verimatrix, (Euronext Paris: VMX, FR0010291245), a global leader in powering the modern connected world with people-centered security, today announced that Bucharest-based Antena

Sensorion Announces Its Participation in the 59th Annual Inner Ear Biology Workshop: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg
Sensorion Announces Its Participation in the 59th Annual Inner Ear Biology Workshop


Regulatory News:



Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within

Median Technologies to Attend and Present at the ESMO Congress 2024, Being Held in Barcelona, Spain, from Sept 13-17, 2024: https://mms.businesswire.com/media/20200113005579/en/767035/5/Median_strapline.jpg
Median Technologies to Attend and Present at the ESMO Congress 2024, Being Held in Barcelona, Spain, from Sept 13-17, 2024


Regulatory News:



Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”) announces today that the Company will attend the European Society for Medical Oncology

EORTC erweitert Medidata-Partnerschaft zur Unterstützung einer neuen Phase der Onkologieforschung: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
EORTC erweitert Medidata-Partnerschaft zur Unterstützung einer neuen Phase der Onkologieforschung


Medidata, eine Marke von Dassault Systèmes und führender Anbieter von Lösungen für klinische Studien in der Biowissenschaftsbranche, und die Europäische Organisation für Forschung und Behandlung

EORTC Extends Medidata Partnership to Help Power New Phase of Oncology Research: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
EORTC Extends Medidata Partnership to Help Power New Phase of Oncology Research


Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, and the European Organisation for Research and Treatment of Cancer (EORTC)

FIGEAC AÉRO: UPDATE TO THE FINANCIAL CALENDAR
FIGEAC AÉRO: UPDATE TO THE FINANCIAL CALENDAR
FIGEAC AÉRO: UPDATE TO THE FINANCIAL CALENDAR
PULLUP ENTERTAINMENT: Warhammer 40,000: Space Marine 2 has reached more than two million unique players
PULLUP ENTERTAINMENT: Warhammer 40,000: Space Marine 2 has reached more than two million unique players
PULLUP ENTERTAINMENT: Warhammer 40,000: Space Marine 2 has reached more than two million unique players
Jio erweitert die Zusammenarbeit mit Verimatrix zur Sicherheit von Videoinhalten: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Jio erweitert die Zusammenarbeit mit Verimatrix zur Sicherheit von Videoinhalten


Verimatrix, (Euronext Paris: VMX, FR0010291245), der führende Anbieter von Sicherheit für Menschen in der modernen vernetzten Welt, gab heute bekannt, dass Jio Platforms Ltd. (Jio), der zweitgrößte

EQS-News: Abivax presents first-half 2024 financial results
EQS-News: Abivax presents first-half 2024 financial results
EQS-News: Abivax presents first-half 2024 financial results
Jio Expands Video Content Security Relationship with Verimatrix: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Jio Expands Video Content Security Relationship with Verimatrix


Regulatory News:



Verimatrix, (Euronext Paris: VMX, FR0010291245), the leader in powering the modern connected world with security made for people, today announced that Jio Platforms Ltd. (Jio)

PULLUP ENTERTAINMENT:    Aurélien Briand appointed Chief Financial Officer and  member of the Executive Committee of PULLUP Entertainment
PULLUP ENTERTAINMENT:   Aurélien Briand appointed Chief Financial Officer and member of the Executive Committee of PULLUP Entertainment
PULLUP ENTERTAINMENT:   Aurélien Briand appointed Chief Financial Officer and member of the Executive Committee of PULLUP Entertainment
Poxel Reports Revenue for the Second Quarter and First Half 2024 and Provides Corporate Update: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Reports Revenue for the Second Quarter and First Half 2024 and Provides Corporate Update


Regulatory News:



POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic

Median Technologies to share positive pivotal data for eyonis™ LCS diagnostic software as medical device at the IASLC 2024 World Conference on Lung Cancer: https://mms.businesswire.com/media/20200113005579/en/767035/5/Median_strapline.jpg
Median Technologies to share positive pivotal data for eyonis™ LCS diagnostic software as medical device at the IASLC 2024 World Conference on Lung Cancer


Regulatory News:



Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”) announces today that the Company will be sharing information on its proprietary

Verimatrix reitet auf der IBC 2024 mit dem Counterspy Showcase auf der Welle der Innovation: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix reitet auf der IBC 2024 mit dem Counterspy Showcase auf der Welle der Innovation


Verimatrix, (Euronext Paris: VMX, FR0010291245), der weltweit führender Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, gab heute seine spannenden Pläne für die IBC 2024 bekannt

Verimatrix to Ride the Waves of Innovation at IBC 2024 with Counterspy Showcase: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix to Ride the Waves of Innovation at IBC 2024 with Counterspy Showcase


Regulatory News:



Verimatrix, (Euronext Paris: VMX, FR0010291245), a global leader in powering the modern connected world with people-centered security, today announced its exciting plans for IBC

Aixial Group migriert spezifisches klinisches Datenportfolio auf die Medidata-Plattform, um eine einzige zuverlässige Informationsquelle zu schaffen und die Datenbanksperre zu beschleunigen: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
Aixial Group migriert spezifisches klinisches Datenportfolio auf die Medidata-Plattform, um eine einzige zuverlässige Informationsquelle zu schaffen und die Datenbanksperre zu beschleunigen


Medidata, eine Marke von Dassault Systèmes und führender Anbieter von Lösungen für klinische Studien in der Life-Science-Branche, gab heute ein neues Projekt mit der Aixial Group, einem

Aixial Group Migrates Specific Clinical Data Portfolio Onto Medidata Platform to Create a Single Source of Truth and Accelerate Database Lock: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
Aixial Group Migrates Specific Clinical Data Portfolio Onto Medidata Platform to Create a Single Source of Truth and Accelerate Database Lock


Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced a new project with Aixial Group, a contract research organization

Eutelsat and SoftBank Corp. Collaborate to Offer Ubiquitous, Low Latency, Secure Connectivity for Businesses and Government Agencies Throughout Japan: https://mms.businesswire.com/media/20191112005524/en/397236/5/Eutelsat_Communications_logo.jpg
Eutelsat and SoftBank Corp. Collaborate to Offer Ubiquitous, Low Latency, Secure Connectivity for Businesses and Government Agencies Throughout Japan


Regulatory News:



Eutelsat Group (ISIN: FR0010221234 - Euronext Paris / London Stock Exchange: ETL) announced today a landmark partnership enabling SoftBank Corp. (SoftBank) to integrate

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO  THE NUMBER OF SHARES AND VOTING RIGHTS  MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Median Technologies to host two webcasts on September 5, 2024: https://mms.businesswire.com/media/20200113005579/en/767035/5/Median_strapline.jpg
Median Technologies to host two webcasts on September 5, 2024


Regulatory News:



Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”) will host two live webcasts on September 5, 2024.



Following the recent release of

Pernod Ricard becomes official partner of Paris Saint-Germain: https://mms.businesswire.com/media/20200212005993/en/773259/5/Createurs_de_Convivialite.jpg
Pernod Ricard becomes official partner of Paris Saint-Germain


Pernod Ricard is announcing its official partnership with Paris Saint-Germain. This new global partnership, the first of its kind for Pernod Ricard, will feature the entire portfolio of the Group's

Sensorion Announces its Participation in the World Congress of Audiology in September 2024 in Paris and will Lead a Symposium on Medical Advances in the Field of Hearing Loss: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg
Sensorion Announces its Participation in the World Congress of Audiology in September 2024 in Paris and will Lead a Symposium on Medical Advances in the Field of Hearing Loss


Regulatory News:



Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within

Median Technologies Announces Pivotal REALITY Study of Its eyonis™ LCS Lung Cancer Diagnostic Met All Primary and Secondary Endpoints: https://mms.businesswire.com/media/20200113005579/en/767035/5/Median_strapline.jpg
Median Technologies Announces Pivotal REALITY Study of Its eyonis™ LCS Lung Cancer Diagnostic Met All Primary and Secondary Endpoints


Regulatory News:



Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, “Median” or “The Company”) announces today that eyonis™ LCS, its proprietary Artificial Intelligence

Kaufman & Broad SA: FITCH RATINGS CONFIRMS KAUFMAN & BROAD'S INVESTMENT GRADE RATING
Kaufman & Broad SA: FITCH RATINGS CONFIRMS KAUFMAN & BROAD'S INVESTMENT GRADE RATING
Kaufman & Broad SA: FITCH RATINGS CONFIRMS KAUFMAN & BROAD'S INVESTMENT GRADE RATING
Pernod Ricard Joins Lewis Hamilton & Casa Lumbre Spirits to Enhance the Success of non-alc Blue Agave Spirit, Almave: https://mms.businesswire.com/media/20200212005993/en/773259/5/Createurs_de_Convivialite.jpg
Pernod Ricard Joins Lewis Hamilton & Casa Lumbre Spirits to Enhance the Success of non-alc Blue Agave Spirit, Almave


Regulatory News:



Press Release – Paris, 29 August 2024



Pernod Ricard (Paris:RI) today announces the acquisition of a minority stake in Almave, a Super Premium non-alc blue agave-based spirit